Dietary resveratrol prevents Alzheimer’s markers and increases life span in SAMP8

David Porquet, Gemma Casadesús, Sergi Bayod, +8

AGE

Neurodegenerative DiseasesAlzheimer's DiseaseAgingLife SpanMedicine +5

Low-dose pterostilbene, but not resveratrol, is a potent neuromodulator in aging and Alzheimer's disease

Jaewon Chang, Agnes M. Rimando, Mercè Pallàs, +7

Neurobiology of Aging

Alzheimer's DiseaseAgingMedicineDementiaNeuropharmacology +10

Neuroprotective Role of Trans-Resveratrol in a Murine Model of Familial Alzheimer's Disease

David Porquet, Christian Griñán‐Ferré, Isidró Ferrer, +4

Journal of Alzheimer s Disease

Insulin assays and reference values.

Didier Chevenne, F. Trivin, David Porquet

PubMed

Neurons from senescence‐accelerated SAMP8 mice are protected against frailty by the sirtuin 1 promoting agents melatonin and resveratrol

Rosa Cristòfol, David Porquet, Rubén Corpas, +5

Journal of Pineal Research

Melatonin induces mechanisms of brain resilience against neurodegeneration

Rubén Corpas, Christian Griñán‐Ferré, Verónica Palomera‐Ávalos, +7

Journal of Pineal Research

ImmunologyProteasome ActivityNeuroinflammationInflammationAlzheimer's Disease +14

Behaviour and cognitive changes correlated with hippocampal neuroinflammaging and neuronal markers in female SAMP8, a model of accelerated senescence

Christian Griñán‐Ferré, Verónica Palomera‐Ávalos, Dolors Puigoriol‐Illamola, +5

Experimental Gerontology

Cognitive ScienceAlzheimer's DiseaseAgingCognitive ChangesLongevity +8

Amyloid and tau pathology of familial Alzheimer’s disease APP/PS1 mouse model in a senescence phenotype background (SAMP8)

David Porquet, Pol Andrés‐Benito, Christian Griñán‐Ferré, +5

AGE

Neurodegenerative DiseasesAlzheimer's DiseaseAgingSenescence Phenotype BackgroundTau Pathology +8

Tau hyperphosphorylation and increased BACE1 and RAGE levels in the cortex of PPARβ/δ-null mice

Emma Barroso, Jaume del Valle, David Porquet, +12

Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease

Molecular NeuroscienceSynaptic TransmissionPhysiologyPparβ/δ-null MiceNeuroscience +7

A thyroxine dosage of 8 μg/kg per day is appropriate for the initial treatment of the majority of infants with congenital hypothyroidism

Guy Touati, Juliane Léger, Jean‐Edmond Toublanc, +7

European Journal of Pediatrics

Initial TreatmentIodine Deficiency DisordersThyroid DiseasePediatricsThyroid Disorders +5